What potential risks of SBRT do you counsel patients on when treating early stage lung cancer with an underlying chronic lung infection?
In a patient with a cavitated lesion with underlying chronic infection (identified as cocci) and SqCC, are there additional risks to SBRT? Should special precautions be taken?
Answer from: Radiation Oncologist at Academic Institution
Interesting problem! I can’t say as I’ve had this exact dilemma. I wish there was a way to post a picture in these questions. I’d be curious to see the lie of this tumor and infection. I’m going to make the educated guess that this is a chronic, highly...